Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Invested Capital (2020 - 2025)

Historic Invested Capital for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $3.1 million.

  • iSpecimen's Invested Capital fell 3482.52% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 3482.52%. This contributed to the annual value of $3.3 million for FY2024, which is 6600.98% down from last year.
  • Latest data reveals that iSpecimen reported Invested Capital of $3.1 million as of Q3 2025, which was down 3482.52% from $621973.0 recorded in Q2 2025.
  • iSpecimen's Invested Capital's 5-year high stood at $29.8 million during Q4 2021, with a 5-year trough of $621973.0 in Q2 2025.
  • Moreover, its 5-year median value for Invested Capital was $12.4 million (2021), whereas its average is $12.9 million.
  • Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 23130.56% in 2021, then crashed by 8978.58% in 2025.
  • Quarter analysis of 5 years shows iSpecimen's Invested Capital stood at $29.8 million in 2021, then crashed by 31.83% to $20.3 million in 2022, then plummeted by 52.04% to $9.7 million in 2023, then crashed by 66.01% to $3.3 million in 2024, then dropped by 7.2% to $3.1 million in 2025.
  • Its Invested Capital stands at $3.1 million for Q3 2025, versus $621973.0 for Q2 2025 and $1.7 million for Q1 2025.